VIROPHARMA INC (VPHM) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 782 transactions totaling $193.9M, demonstrating a bullish sentiment with $38.6M in net insider flow. The most recent transaction on Jan 24, 2014 involved a transaction of 154,058 shares valued at $7.7M.
No significant insider buying has been recorded for VPHM in the recent period.
No significant insider selling has been recorded for VPHM in the recent period.
Based on recent SEC filings, insider sentiment for VPHM is bullish with an Insider Alignment Score of 60/100 and a net flow of $38.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at VIROPHARMA INC (VPHM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading VPHM stock, having executed 782 transactions in the past 90 days. The most active insider is Felix Baker (Executive), who has made 110 transactions totaling $68.9M.
Get notified when executives and directors at VPHM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 24, 2014 | Broom Colin Md | Executive | Tender | 154,058 | $50.00 | $7.7M | Large |
| Jan 24, 2014 | Broom Colin Md | Executive | Disposition | 48,878 | $N/A | $0 | |
| Jan 24, 2014 | Broom Colin Md | Executive | Award | 48,878 | $N/A | $0 | |
| Jan 24, 2014 | F. Doyle Thomas | Executive | Disposition | 48,878 | $N/A | $0 | |
| Jan 24, 2014 | F. Doyle Thomas | Executive | Tender | 112,089 | $50.00 | $5.6M | Large |
| Jan 24, 2014 | F. Doyle Thomas | Executive | Award | 48,878 | $N/A | $0 | |
| Jan 24, 2014 | C. Fletcher Robert | Executive | Tender | 37,227 | $50.00 | $1.9M | Large |
| Jan 24, 2014 | C. Fletcher Robert | Executive | Disposition | 48,878 | $N/A | $0 | |
| Jan 24, 2014 | C. Fletcher Robert | Executive | Award | 48,878 | $N/A | $0 | |
| Jan 24, 2014 | J. Kirby John | Executive | Tender | 60 | $50.00 | $3.0K | |
| Jan 24, 2014 | J. Kirby John | Executive | Award | 1,980 | $N/A | $0 | |
| Jan 24, 2014 | J. Kirby John | Executive | Disposition | 1,980 | $N/A | $0 | |
| Jan 24, 2014 | Milano Vincent | Executive | Award | 311,798 | $N/A | $0 | |
| Jan 24, 2014 | Milano Vincent | Executive | Disposition | 311,798 | $N/A | $0 | |
| Jan 24, 2014 | Milano Vincent | Executive | Tender | 482,281 | $50.00 | $24.1M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 228 | $116.3M | 35.8% |
Sale(S) | 214 | $77.7M | 23.9% |
Tender(U) | 16 | $74.0M | 22.8% |
Payment(F) | 78 | $32.4M | 10.0% |
Exercise(M) | 202 | $24.6M | 7.6% |
Other(J) | 10 | $56.6K | 0.0% |
Award(A) | 25 | $12.2K | 0.0% |
Disposition(D) | 9 | $0 | 0.0% |
Insider activity at VIROPHARMA INC shows mixed signals across all time. While $116.3M in purchases indicates some executive confidence,$77.7M in sales balances the picture, resulting in a modest net flow of $38.6M.26 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Felix Baker, has transacted $68.9M during this period.